Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project

Autor: Pilar Retamar, Carmen Herrero-Rodríguez, Lucia Valiente de Santis, Natalia Maldonado, Patricia Jiménez-Aguilar, M Ángeles Esteban-Moreno, M Pilar Aznarte-Padial, Andrés Martín-Aspas, Francisco Anguita-Santos, Clara M Rosso-Fernández, Zaira R. Palacios-Baena, Juan José Castón, Jesús Rodríguez-Baño, Juan Enrique Corzo-Delgado, Salvador López-Cárdenas, Guillermo Ojeda-Burgos, Franciso J Martínez-Marcos, Julia Praena-Segovia, Irene Borreguero Borreguero

Publikováno v: BMJ Open, Vol 10, Iss 7 (2020)
BMJ Open 2020;10:e035460
RODIN: Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Universidad de Cádiz
BMJ Open
Digital.CSIC. Repositorio Institucional del CSIC
instname
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz

[Introduction] Ceftaroline, tedizolid, dalbavancin, ceftazidime-avibactam and ceftolozane-tazobactam are novel antibiotics used to treat infections caused by multidrug-resistant pathogens (MDR). Their use should be supervised and monitored as part of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d91c756dd770725e56062ca163d938b
https://bmjopen.bmj.com/content/10/7/e035460.full